---
schema_version: "secwatch.filing_event.v1"
accession: "0001503274-25-000002"
form_type: "8-K"
ticker: "QTRX"
cik: "0001503274"
company_name: "Quanterix Corp"
filed_at: "2025-01-10T23:59:59+00:00"
generated_at: "2026-05-28T04:52:59.994066+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Quanterix to acquire Akoya Biosciences in stock deal; exchange ratio 0.318

## Summary
- Akoya shareholders to receive 0.318 Quanterix shares per share; no cash consideration except for fractional shares.
- Voting agreements from ~55.9% of Akoya stock and ~6.2% of Quanterix stock; lock-up agreements cover ~35.7% of QTRX shares for 90 days.
- Termination fees: $7M from Akoya, $9M from Quanterix; Quanterix may provide $30M bridge convertible notes after March 15, 2025.
- Expected close by July 9, 2025 (extendable to Jan 9, 2026); Akoya to nominate two directors to Quanterix board.

## SEC filing metadata
- accession: 0001503274-25-000002
- form_type: 8-K
- ticker: QTRX
- cik: 0001503274
- company_name: Quanterix Corp
- filed_at: 2025-01-10T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1503274/000150327425000002/0001503274-25-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1503274/000150327425000002/qtrx-20250109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001503274-25-000002
- JSON: https://secwatch.observer/filing/0001503274-25-000002.json
- Plain text: https://secwatch.observer/filing/0001503274-25-000002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.